RP

Rasmi Puthiyadathidathil

Active Director Director DIN 10858857
DIN 10858857 First appointment Dec 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Rasmi Puthiyadathidathil

Data last updated:

Rasmi Puthiyadathidathil is a Director at Med Salorix Formulation Private Limited (since 2024). The company operates in Paper.

DIN 10858857
Primary Designation Director
Industry Paper
First Appointment 02 Dec 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Dec 20242024Active

Board colleagues of Rasmi Puthiyadathidathil

NameDINCompanyDesignation
Sajana Perumparambil Narayanan10858856Med Salorix Formulation Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Med Salorix Formulation Private Limited
Premium access

Shareholding and investment profile for Rasmi Puthiyadathidathil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rasmi Puthiyadathidathil

Rasmi Puthiyadathidathil currently holds 1 directorship: Med Salorix Formulation Private Limited (Director, since 02 Dec 2024).

Rasmi Puthiyadathidathil was first appointed on 02 Dec 2024 as Director at Med Salorix Formulation Private Limited.

The current boards of Rasmi Puthiyadathidathil's companies include Sajana Perumparambil Narayanan (Med Salorix Formulation Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available